Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica (Q58419706)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

[SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Montserrat Barbany

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Basilio Moreno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Miguel A Rubio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Grupo Colaborativo de la SEEDO

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

184-96; quiz 1 p following 200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

Establishing a standard definition for child overweight and obesity worldwide: international survey

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Obesidad infantil y juvenil en España. Resultados del Estudio enKid (1998-2000)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Prevalencia de obesidad en España

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

[Prevalence of obesity in the Spanish adult population: 14 years of continuous increase]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Prevalence of overweight and obesity in elderly people in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Influence of sociodemographic factors in the prevalence of obesity in Spain. The SEEDO'97 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

The size of obesity differences associated with educational level in Spain, 1987 and 1995/97.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

The metabolic syndrome--a new worldwide definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Central adiposity determines prevalence differences of the metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Prevalencia del síndrome metabólico en la población de la Comunidad Canaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Factores de riesgo cardiovascular en el sobrepeso y la obesidad. Variaciones tras tratamiento de pérdida ponderal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

The effect of age on the association between body-mass index and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Body mass index and mortality among US male physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

7 January 2021

Obesity in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Should we recommend low-fat diets for obesity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Dietary fat, insulin sensitivity and the metabolic syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Very low energy diets in the treatment of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Intermittent versus on-demand use of a very low calorie diet: a randomized 2-year clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Physical activity considerations for the treatment and prevention of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Physical activity and weight loss: does prescribing higher physical activity goals improve outcome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Behavioral treatment of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Randomized trial of lifestyle modification and pharmacotherapy for obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

A systematic review of the clinical effectiveness of orlistat used for the management of obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Meta-analysis: pharmacologic treatment of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Orlistat inhibits dietary cholesterol absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Orlistat for obesity: benefits beyond weight loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Effect of orlistat on postprandial lipemia, NMR lipoprotein subclass profiles and particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Thermogenic effects of sibutramine in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

The efficacy and safety of sibutramine for weight loss: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Use of sibutramine, an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Endocannabinoid control of food intake and energy balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Complementary therapies for reducing body weight: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Surgical treatment of obesity and its effect on diabetes: 10-y follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Bariatric surgery: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Meta-analysis: surgical treatment of obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Vertical banded gastroplasty at more than 5 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Laparoscopic adjustable gastric banding: lessons from the first 500 patients in a single institution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Experience with Lap-band System up to 7 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Complications after laparoscopic gastric bypass: a review of 3464 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Biliopancreatic diversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Nutritional deficiencies following bariatric surgery: what have we learned?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

What becomes of patients one year after the intragastric balloon has been removed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Intragastric balloon for preoperative weight reduction in candidates for laparoscopic gastric bypass with massive obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Mechanisms of action of the implantable gastric stimulator for obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Preschool physical activity level and change in body fatness in young children. The Framingham Children's Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Weight-control behaviors among adolescent girls and boys: implications for dietary intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Prevention of obesity in young children: a critical challenge for medical professionals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Family involvement in weight control, weight maintenance and weight-loss interventions: a systematic review of randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Prevention of pediatric overweight and obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Environmental changes may be needed for prevention of overweight in minority children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Coordinated school health program and dietetics professionals: partners in promoting healthful eating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Obesity in children and young people: a crisis in public health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Food messages on African American television shows.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

Treatment and prevention of obesity: what works, what doesn't work, and what might work

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2807%2972531-9

10.1016/S0025-7753(07)72531-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17298782%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference